miR-29b inhibits the progression of multiple myeloma through downregulating FOXP1.

CONCLUSIONS: miR-29b recedes the progression of MM via downregulating FOXP1, which may provide a potential biological target for MM treatment. PMID: 30068241 [PubMed - as supplied by publisher]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research